Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Upcoming)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewImmunologyTransplantation Open Access | 10.1172/JCI125986

IFNGR/STAT1 signaling in recipient hematopoietic antigen presenting cells suppresses graft-versus-host disease

Caisheng Lu,1 Huihui Ma,1 Liangsong Song,1 Hui Wang,1 Lily Wang,1 Shirong Li,2 Stephen M. Lagana,3 Antonia R. Sepulveda,4 Kasper Hoebe,5 Samuel S. Pan,6 Yong-Guang Yang,7 Suzanne Lentzsch,2 and Markus Y. Mapara1

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Lu, C. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Ma, H. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Song, L. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Wang, H. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Wang, L. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Li, S. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Lagana, S. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Sepulveda, A. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Hoebe, K. in: JCI | PubMed | Google Scholar |

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Pan, S. in: JCI | PubMed | Google Scholar |

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Yang, Y. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Lentzsch, S. in: JCI | PubMed | Google Scholar

1Columbia Center for Translational Immunology, Columbia University, New York, United States of America

2Division of Hematology/Oncology, Columbia University, New York, United States of America

3Department of Pathology and Cell Biology, Columbia University, New York, United States of America

4Department of Pathology and Cell Biology, George Washington University, Washington DC, United States of America

5Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, United States of America

6Cancer Biostatistics Shared Resource, Herbert Irving Columbia Cancer Center, New York, United States of America

7Columbia University, New York, United States of America

Find articles by Mapara, M. in: JCI | PubMed | Google Scholar |

Published November 29, 2022 - More info

J Clin Invest. https://doi.org/10.1172/JCI125986.
Copyright © 2022, Lu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 29, 2022 - Version history
View PDF
Abstract

Absence of Interferon-γ Receptor (IFNGR) or Signal Transducer and Activator of Transcription 1 (STAT1) signaling in donor cells has been shown to result in reduced acute GVHD induction. In this study, we unexpectedly observed increased activation and expansion of donor lymphocytes in both lymphohematopoietic organs and GVHD target tissues of IFNGR/STAT1-deficient recipient mice, leading to rapid mortality following the induction of GVHD. Lipopolysaccharide (LPS)-matured bone marrow-derived Ifngr1-/-/Stat1-/- dendritic cells (BMDCs) were more potent allogeneic stimulators and expressed increased levels of MHC II and costimulatory molecules. Similar effects were observed in human APCs with knockdown of Stat1 by CRISPR/Cas9 and treatment with a JAK1/2 inhibitor. Furthermore, we demonstrated that the absence of IFNGR/STAT1 signaling in hematopoietic APCs impaired the presentation of exogenous antigens while promoting the presentation of endogenous antigens. In contrast, the indirect presentation of host antigens to donor lymphocytes was defective in IFNGR/STAT1-deficient donor-derived APCs in fully donor chimeric mice. The differential effects of IFNGR/STAT1 signaling on endogenous and exogenous antigen presentation could provide further insight into the roles of the IFN-γ/STAT1 signal pathway in the pathogenesis of GVHD, organ rejection, and autoimmune diseases.

Graphical Abstract
graphical abstract
Supplemental material

View

Version history
  • Version 1 (November 29, 2022): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts